Rare diseases
Investigational molecules
Locations
Back to Greece1 004 clinical trials in Piraeus, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders
GreeceA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
GreeceA study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis
GreeceA study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection
GreeceA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
GreeceA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
GreeceA study of MK-1084 and a drug combination for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations.
GreeceA study to evaluate the safety and effectiveness of VTX2735 sodium in patients with recurrent pericarditis
GreeceA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
GreeceA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
GreeceA study to evaluate the safety and effectiveness of empasiprubart and efgartigimod alfa in patients with generalized myasthenia gravis.
GreeceA study of pembrolizumab, cetuximab, and MK-1084 for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations
GreeceThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, particularly in non-small cell lung cancer and novel therapeutic combinations. Studies include investigations of targeted therapies and immunotherapy approaches.
Innovative research combining standard treatments with new therapeutic agents to improve patient outcomes.
Research initiatives targeting heart failure prevention and stroke prevention in patients with atrial fibrillation. Studies evaluate new therapeutic approaches for managing cardiovascular risks.
Trials focusing on both preventive measures and treatment of established cardiovascular conditions.
Clinical investigations in multiple myeloma and related blood disorders, exploring combination therapies and novel treatment approaches for patients with various blood-related conditions.
Studies examining innovative therapeutic combinations for improved patient outcomes.
Research focusing on treating Crohn's Disease and other inflammatory conditions, evaluating new therapeutic options and combination treatments for better disease management.
Studies aimed at improving treatment outcomes in chronic inflammatory diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
